JULIE GRUSZCZYNSKI: Open Payments
NPI 1225783061 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 14 payments from 10 companies in 2025. Trend: 2023 $220 · 2024 $1,425 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $146 |
| Verrica Pharmaceuticals Inc. | 1 | $142 |
| Exelixis Inc. | 1 | $105 |
| UCB, Inc. | 2 | $59 |
| GENZYME CORPORATION | 1 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $18 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
Products named: YCANTH, RYBREVANT, CABOMETYX, Bimzelx, DUPIXENT, Leqselvi, TALTZ, COSENTYX.
Industry payments across IL — which companies pay providers there.
